TABLE 2.

PDRG1 IHC staining and clinicopathological characteristics of 96 glioma patients

Variable	Number (n)	PDRG1 IHC staining
		Low (%)	High (%)	Χ 2	P
Sex				1.099	0.294
Male	59	32 (54.2)	27 (45.8)
Female	37	16 (43.2)	21 (56.8)
Age				0.677	0.411
<50 years	42	23 (54.8)	19 (45.2)
≥50 years	54	25 (46.3)	29 (53.7)
Tumor size				3.270	0.071
<5 cm	31	19 (61.3)	12 (38.7)
≥5 cm	29	11 (37.9)	18 (62.1)
WHO grade				8.709	0.003
Low (Ⅰ‐Ⅱ)	27	20 (74.1)	7 (25.9)
High (Ⅲ‐Ⅳ)	69	28 (40.6)	41 (59.4)